Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Generon (Shanghai) Corp. Ltd.
DescriptionLong-acting recombinant fusion protein containing human granulocyte colony-stimulating factor (G-CSF; CSF3)
Molecular Target Granulocyte colony-stimulating factor (G-CSF) (CSF3)
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPhase II
Standard IndicationNeutropenia
Indication DetailsTreat chemotherapy-induced neutropenia (CIN); Treat neutropenia in cancer patients after high-dose chemotherapy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today